GlassScriptPhysician profile
Chao Li
NPI 1154819290
$5,410.64
in general payments reported to CMS, 2019-2025
20 companies · $1,289 in 2025
The $1,289 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $592 · 2023: $1,091 · 2024: $2,438 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,782 · Travel and Lodging: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,782.07 |
| Travel and Lodging | $1,036.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $3,396.22 | 2022-2025 | Lensx, Hydrus Microstent, Clareon |
| Abbvie INC. | $416.48 | 2022-2025 | |
| Sight Sciences, INC. | $354.13 | 2023-2024 | Omni Surgical System |
| Bausch & Lomb Americas INC. | $276.83 | 2023-2025 | Miebo, Xiidra, Envista Envy Iol |
| Johnson & Johnson Surgical Vision, INC. | $167.61 | 2023-2024 | Tecnis Simplicity, Tecnis Iol |
| Harrow Eye, LLC | $152.99 | 2025 | Vevye |
| Astellas Pharma US INC | $122.77 | 2025 | Izervay |
| Optinose US, INC. | $111.78 | 2024-2025 | |
| Axogen | $91.39 | 2023-2024 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Ha+ Nerve Protector |
| Smith+Nephew, INC. | $51.03 | 2023-2024 | Stravix |
| Amgen INC. | $43.68 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $38.70 | 2025 | Xdemvy |
| Merck Sharp & Dohme LLC | $33.36 | 2025 | Keytruda |
| Genzyme Corporation | $28.78 | 2024 | |
| Rayner Intraocular Lenses Limited | $24.89 | 2025 | Omidria |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $23.78 | 2023 | Auvi-Q |
| Biotissue Holdings INC. | $21.00 | 2025 | |
| Baxter Healthcare | $20.19 | 2024 | Perclot |
| Eyepoint US, INC. | $19.70 | 2022 | |
| Medtronic, INC. | $15.33 | 2024 | Propel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chao Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.